{"id":"https://openalex.org/W4245721144","doi":"https://doi.org/10.1093/neuonc/noy148.359","title":"EXTH-10. A VERSATILE AND MODULAR TARGETED NANOPARTICLE PLATFORM FOR DELIVERY OF COMBINATION THERAPIES TO ADULT AND PEDIATRIC CNS TUMORS","display_name":"EXTH-10. A VERSATILE AND MODULAR TARGETED NANOPARTICLE PLATFORM FOR DELIVERY OF COMBINATION THERAPIES TO ADULT AND PEDIATRIC CNS TUMORS","publication_year":2018,"publication_date":"2018-11-01","ids":{"openalex":"https://openalex.org/W4245721144","doi":"https://doi.org/10.1093/neuonc/noy148.359"},"language":"en","primary_location":{"id":"doi:10.1093/neuonc/noy148.359","doi":"https://doi.org/10.1093/neuonc/noy148.359","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noy148.359","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/20/suppl_6/vi87/26281111/noy148.359.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://academic.oup.com/neuro-oncology/article-pdf/20/suppl_6/vi87/26281111/noy148.359.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024414501","display_name":"Fred C. Lam","orcid":"https://orcid.org/0000-0002-9801-5037","observed_orcids":["https://orcid.org/0000-0002-9801-5037"]},"institutions":[{"id":"https://openalex.org/I4390039253","display_name":"Koch Institute for Integrative Cancer Research At MIT","ror":"https://ror.org/01xd6q208","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039253","https://openalex.org/I63966007"]},{"id":"https://openalex.org/I63966007","display_name":"Massachusetts Institute of Technology","ror":"https://ror.org/042nb2s44","country_code":"US","type":"education","lineage":["https://openalex.org/I63966007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fred Lam","raw_affiliation_strings":["Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4390039253","https://openalex.org/I63966007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111203143","display_name":"Stephen W. Morton","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039253","display_name":"Koch Institute for Integrative Cancer Research At MIT","ror":"https://ror.org/01xd6q208","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039253","https://openalex.org/I63966007"]},{"id":"https://openalex.org/I63966007","display_name":"Massachusetts Institute of Technology","ror":"https://ror.org/042nb2s44","country_code":"US","type":"education","lineage":["https://openalex.org/I63966007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen Morton","raw_affiliation_strings":["Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4390039253","https://openalex.org/I63966007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029282011","display_name":"Jeffrey B. Wyckoff","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039253","display_name":"Koch Institute for Integrative Cancer Research At MIT","ror":"https://ror.org/01xd6q208","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039253","https://openalex.org/I63966007"]},{"id":"https://openalex.org/I63966007","display_name":"Massachusetts Institute of Technology","ror":"https://ror.org/042nb2s44","country_code":"US","type":"education","lineage":["https://openalex.org/I63966007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey Wyckoff","raw_affiliation_strings":["Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4390039253","https://openalex.org/I63966007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110725461","display_name":"Tu\u2010Lan Vu\u2010Han","orcid":"https://orcid.org/0000-0002-9993-6882","observed_orcids":["https://orcid.org/0000-0002-9993-6882"]},"institutions":[{"id":"https://openalex.org/I4390039253","display_name":"Koch Institute for Integrative Cancer Research At MIT","ror":"https://ror.org/01xd6q208","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039253","https://openalex.org/I63966007"]},{"id":"https://openalex.org/I63966007","display_name":"Massachusetts Institute of Technology","ror":"https://ror.org/042nb2s44","country_code":"US","type":"education","lineage":["https://openalex.org/I63966007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tu-Lan Vu Han","raw_affiliation_strings":["Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4390039253","https://openalex.org/I63966007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102150590","display_name":"Mun Kyung Hwang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039253","display_name":"Koch Institute for Integrative Cancer Research At MIT","ror":"https://ror.org/01xd6q208","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039253","https://openalex.org/I63966007"]},{"id":"https://openalex.org/I63966007","display_name":"Massachusetts Institute of Technology","ror":"https://ror.org/042nb2s44","country_code":"US","type":"education","lineage":["https://openalex.org/I63966007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mun Hwang","raw_affiliation_strings":["Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4390039253","https://openalex.org/I63966007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036041519","display_name":"Amanda Maffa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039253","display_name":"Koch Institute for Integrative Cancer Research At MIT","ror":"https://ror.org/01xd6q208","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039253","https://openalex.org/I63966007"]},{"id":"https://openalex.org/I63966007","display_name":"Massachusetts Institute of Technology","ror":"https://ror.org/042nb2s44","country_code":"US","type":"education","lineage":["https://openalex.org/I63966007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amanda Maffa","raw_affiliation_strings":["Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4390039253","https://openalex.org/I63966007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008443498","display_name":"Elena Balkanska-Sinclair","orcid":"https://orcid.org/0000-0001-8271-635X","observed_orcids":["https://orcid.org/0000-0001-8271-635X"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elena Balkanska-Sinclair","raw_affiliation_strings":["Duke University School of Medicine, Durham, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University School of Medicine, Durham, NC, USA","institution_ids":["https://openalex.org/I170897317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073615852","display_name":"Michael B. Yaffe","orcid":"https://orcid.org/0000-0002-9547-3251","observed_orcids":["https://orcid.org/0000-0002-9547-3251"]},"institutions":[{"id":"https://openalex.org/I4390039253","display_name":"Koch Institute for Integrative Cancer Research At MIT","ror":"https://ror.org/01xd6q208","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039253","https://openalex.org/I63966007"]},{"id":"https://openalex.org/I63966007","display_name":"Massachusetts Institute of Technology","ror":"https://ror.org/042nb2s44","country_code":"US","type":"education","lineage":["https://openalex.org/I63966007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Yaffe","raw_affiliation_strings":["Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4390039253","https://openalex.org/I63966007"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007348475","display_name":"Scott Floyd","orcid":"https://orcid.org/0000-0002-8067-2426","observed_orcids":["https://orcid.org/0000-0002-8067-2426"]},"institutions":[{"id":"https://openalex.org/I170897317","display_name":"Duke University","ror":"https://ror.org/00py81415","country_code":"US","type":"education","lineage":["https://openalex.org/I170897317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Scott Floyd","raw_affiliation_strings":["Duke University School of Medicine, Durham, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Duke University School of Medicine, Durham, NC, USA","institution_ids":["https://openalex.org/I170897317"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069094503","display_name":"Paula Therese Hammond","orcid":"https://orcid.org/0000-0002-9835-192X","observed_orcids":["https://orcid.org/0000-0002-9835-192X"]},"institutions":[{"id":"https://openalex.org/I4390039253","display_name":"Koch Institute for Integrative Cancer Research At MIT","ror":"https://ror.org/01xd6q208","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039253","https://openalex.org/I63966007"]},{"id":"https://openalex.org/I63966007","display_name":"Massachusetts Institute of Technology","ror":"https://ror.org/042nb2s44","country_code":"US","type":"education","lineage":["https://openalex.org/I63966007"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paula Hammond","raw_affiliation_strings":["Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA, USA","institution_ids":["https://openalex.org/I4390039253","https://openalex.org/I63966007"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5132,"currency":"USD","value_usd":5132},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"20","issue":"suppl_6","first_page":"vi87","last_page":"vi87"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.0024999999441206455,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/blood-brain-barrier-penetration","display_name":"blood-brain barrier penetration","score":0.8289999961853027},{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.8730000257492065},{"id":"https://openalex.org/keywords/medulloblastoma","display_name":"medulloblastoma","score":0.8930000066757202},{"id":"https://openalex.org/keywords/temozolomide","display_name":"temozolomide","score":0.9810000061988831},{"id":"https://openalex.org/keywords/intravital-imaging","display_name":"intravital imaging","score":0.7260000109672546},{"id":"https://openalex.org/keywords/nanoparticle-uptake","display_name":"nanoparticle uptake","score":0.4230000078678131},{"id":"https://openalex.org/keywords/pediatric-brain-tumors","display_name":"pediatric brain tumors","score":0.6700000166893005},{"id":"https://openalex.org/keywords/drug-toxicity-reduction","display_name":"drug toxicity reduction","score":0.4740000069141388}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5801571607589722},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5600395202636719},{"id":"https://openalex.org/C2777389519","wikidata":"https://www.wikidata.org/wiki/Q425088","display_name":"Temozolomide","level":3,"score":0.5520956516265869},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5020813941955566},{"id":"https://openalex.org/C2778402981","wikidata":"https://www.wikidata.org/wiki/Q221694","display_name":"Blood\u2013brain barrier","level":3,"score":0.5010745525360107},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.4953562021255493},{"id":"https://openalex.org/C2781209748","wikidata":"https://www.wikidata.org/wiki/Q419953","display_name":"Topotecan","level":3,"score":0.48688116669654846},{"id":"https://openalex.org/C2780789225","wikidata":"https://www.wikidata.org/wiki/Q1333608","display_name":"Medulloblastoma","level":2,"score":0.4643687605857849},{"id":"https://openalex.org/C126511603","wikidata":"https://www.wikidata.org/wiki/Q1261145","display_name":"Targeted drug delivery","level":3,"score":0.4230271279811859},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.4229177236557007},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.38068926334381104},{"id":"https://openalex.org/C2778227246","wikidata":"https://www.wikidata.org/wiki/Q1365309","display_name":"Glioma","level":2,"score":0.3462947607040405},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2598656415939331},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2298092246055603},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.15084519982337952},{"id":"https://openalex.org/C529278444","wikidata":"https://www.wikidata.org/wiki/Q47273","display_name":"Central nervous system","level":2,"score":0.12124946713447571},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1093/neuonc/noy148.359","doi":"https://doi.org/10.1093/neuonc/noy148.359","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noy148.359","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/20/suppl_6/vi87/26281111/noy148.359.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6217026","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6217026","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro Oncol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1093/neuonc/noy148.359","doi":"https://doi.org/10.1093/neuonc/noy148.359","is_oa":true,"landing_page_url":"https://doi.org/10.1093/neuonc/noy148.359","pdf_url":"https://academic.oup.com/neuro-oncology/article-pdf/20/suppl_6/vi87/26281111/noy148.359.pdf","source":{"id":"https://openalex.org/S106908163","display_name":"Neuro-Oncology","issn_l":"1522-8517","issn":["1522-8517","1523-5866"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neuro-Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4245721144.pdf","grobid_xml":"https://content.openalex.org/works/W4245721144.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2899825807","https://openalex.org/W2767454380","https://openalex.org/W2804818197","https://openalex.org/W4240434349","https://openalex.org/W4224243873","https://openalex.org/W4382068599","https://openalex.org/W2796594559","https://openalex.org/W4413304198","https://openalex.org/W2108294913","https://openalex.org/W1968074097"],"abstract_inverted_index":{"Effective":[0],"treatment":[1],"of":[2,10,67,88,112,118,189,205,219],"CNS":[3,50,232],"tumors":[4,211],"is":[5],"limited":[6],"by":[7],"the":[8,11,43,86,92,128,187,203,216],"presence":[9],"blood-brain":[12],"barrier":[13],"(BBB)":[14],"and":[15,58,104,114,127,141,154,196,230],"rapid":[16],"resistance":[17],"to":[18,45,49,70,90,133,148,160,194,208,223,228],"single":[19],"agent":[20],"therapies.":[21],"To":[22],"address":[23],"these":[24],"issues,":[25],"we":[26,84],"developed":[27],"nanoparticles":[28],"(NPs)":[29],"that":[30,143],"can":[31],"be":[32],"functionalized":[33],"with":[34,121,124,137,145,163,172,179],"ligands,":[35],"such":[36,212],"as":[37,99,101,213],"transferrin":[38],"(Tf-NPs),":[39],"for":[40],"delivery":[41],"across":[42],"BBB":[44,94],"deliver":[46,224],"multiple":[47],"cargo":[48],"tumors.":[51,233],"In":[52],"vitro":[53],"uptake":[54,66],"studies":[55],"in":[56,73,95,108,151,157,166],"U87MG":[57,113],"GL261":[59,115],"GBM":[60],"cell":[61],"lines":[62],"demonstrate":[63],"increased":[64,138],"intracellular":[65],"Tf-NPs":[68,89,122],"compared":[69,159],"non-functionalized":[71,167],"NPs":[72,168,207],"a":[74,81,146],"time-dependent":[75],"manner.":[76],"Using":[77],"intravital":[78,199],"imaging":[79,200],"through":[80],"cranial":[82],"window,":[83],"show":[85,183],"ability":[87,204],"traverse":[91],"intact":[93],"non-tumor":[96],"bearing":[97],"mice":[98,120,161,170,177],"well":[100],"achieve":[102],"direct":[103],"durable":[105],"tumor":[106,152],"binding":[107],"intracranial":[109],"orthotopic":[110],"models":[111],"GBM.":[116],"Treatment":[117],"tumor-bearing":[119],"loaded":[123],"temozolomide":[125],"(TMZ)":[126],"bromodomain":[129],"inhibitor":[130],"JQ1":[131],"leads":[132],"superior":[134],"therapeutic":[135],"effects":[136,188],"DNA":[139],"damage":[140],"apoptosis":[142],"correlates":[144],"1.5-":[147],"2-fold":[149],"decrease":[150],"burden":[153],"corresponding":[155],"increase":[156],"survival":[158],"treated":[162,171,178],"drugs":[164,181],"packaged":[165],"or":[169],"equivalent":[173],"free-drug":[174],"dosing.":[175],"Immunocompetent":[176],"Tf-NP-loaded":[180],"also":[182],"relative":[184],"protection":[185],"from":[186],"systemic":[190],"drug":[191],"toxicity":[192],"due":[193],"TMZ":[195],"JQ1.":[197],"Preliminary":[198],"further":[201],"shows":[202],"our":[206],"target":[209],"pediatric":[210,231],"medulloblastoma,":[214],"demonstrating":[215],"preclinical":[217],"potential":[218],"this":[220],"nanoscale":[221],"platform":[222],"novel":[225],"combination":[226],"therapies":[227],"adult":[229]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-05-12T00:00:00"}